Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Anticancer drug use in geriatric patients: concerns and challenges.

Lau DT, Jarzebowski MH, McKoy JM.

Clin Ther. 2011 Oct;33(10):1408-12. doi: 10.1016/j.clinthera.2011.07.004. No abstract available.

PMID:
22036129
2.

Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project.

Franchi C, Lucca U, Tettamanti M, Riva E, Fortino I, Bortolotti A, Merlino L, Pasina L, Nobili A.

Pharmacoepidemiol Drug Saf. 2011 May;20(5):497-505. doi: 10.1002/pds.2124.

PMID:
21432941
3.

Utilization of lipid-lowering drugs in men and women. a reflection of the research evidence?

Savoie I, Kazanjian A.

J Clin Epidemiol. 2002 Jan;55(1):95-101.

PMID:
11781127
4.

Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.

Navarro RP, Morrow T, Baran R.

Manag Care Interface. 2002 Jul;15(7):55-62.

PMID:
12143298
5.

Cancer chemotherapy in elderly cancer patients.

Balducci L.

J Oncol Manag. 2005 Spring;14(2):35-8.

PMID:
16018197
6.

Inappropriate prescribing in the elderly.

Gallagher P, Barry P, O'Mahony D.

J Clin Pharm Ther. 2007 Apr;32(2):113-21. Review.

PMID:
17381661
7.

Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level.

Pugh MJ, Rosen AK, Montez-Rath M, Amuan ME, Fincke BG, Burk M, Bierman A, Cunningham F, Mortensen EM, Berlowitz DR.

Med Care. 2008 Feb;46(2):167-73. doi: 10.1097/MLR.0b013e318158aec2.

PMID:
18219245
8.

Hospital resource utilization and functional decline of geriatric patients.

Murray ME, Wells TJ, Callen BL.

Nurs Econ. 2003 May-Jun;21(3):114-9. No abstract available.

PMID:
12847984
9.

Targeting of home-delivered meals programs to older adults in the United States.

Lee J, Frongillo EA, Keating MA, Deutsch LH, Daitchman J, Frongillo DE.

J Nutr Elder. 2008;27(3-4):405-15.

PMID:
19042582
10.

Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.

Noize P, Bazin F, Dufouil C, Lechevallier-Michel N, Ancelin ML, Dartigues JF, Tzourio C, Moore N, Fourrier-R├ęglat A.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):310-9. doi: 10.1002/pds.1717.

PMID:
19241438
11.

Datapoints: psychotropic drug use among elderly patients in home care in the United States.

Bali V, Chatterjee S, Aparasu RR.

Psychiatr Serv. 2012 Jan;63(1):6. doi: 10.1176/appi.ps.2012000p6. No abstract available.

PMID:
22227752
12.

The role of consultant pharmacists in reducing medication problems among older adults receiving Medicaid waiver services.

Alkema GE, Enguidanos SM, Wilber KH, Trufasiu M, Simmons WJ, Frey D.

Consult Pharm. 2009 Feb;24(2):121-33.

PMID:
19275454
13.

[Geriatric oncology: an emergent subspecialty].

Freyer G, Falandry C.

Rev Med Interne. 2013 Oct;34(10):589-90. doi: 10.1016/j.revmed.2013.04.002. Epub 2013 May 18. French. No abstract available.

PMID:
23694957
14.

The role of databases in drug postmarketing surveillance.

Rodriguez EM, Staffa JA, Graham DJ.

Pharmacoepidemiol Drug Saf. 2001 Aug-Sep;10(5):407-10.

PMID:
11802586
15.

Management of cancer in the elderly: an essential need for more clinically relevant data.

Markman M.

Oncology. 2013;85(3):166-7. doi: 10.1159/000351502. Epub 2013 Aug 30. No abstract available.

16.

[Restructuring of health care services--mostly consequences for the elderly].

Anell A, Hjortsberg C.

Lakartidningen. 2001 Feb 7;98(6):560-4. Swedish. No abstract available.

PMID:
11475243
17.

Cost-effective systems of care for senior populations.

Boult C, Boult L, Pacala JT.

Cost Qual Q J. 1998 Jun;4(2):10-6, 36. No abstract available.

PMID:
10182592
18.

Drugs and the elderly, Part 1: The problems facing managed care.

Beers MH, Baran RW, Frenia K.

Am J Manag Care. 2000 Dec;6(12):1313-20. Review.

19.

Medicaid drug utilization review: a critical appraisal.

Moore WJ.

Med Care Rev. 1994 Spring;51(1):3-37. Review. No abstract available.

PMID:
10133004
20.

Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.

Arbuckle RB, Griffith NL, Iacovelli LM, Johnson PE, Jorgenson JA, Kloth DD, Lucarelli CD, Muller RJ.

Pharmacotherapy. 2008 May;28(5 Pt 2):1S-15S. doi: 10.1592/phco.28.5supp.1S.

PMID:
18447704

Supplemental Content

Support Center